Table 2.

Comparison of different regimens mixed‐comparison model on number of patients achieving IOP≤18 mmHg

PGA
0.29 (0.13, 0.64)	AA
0.32 (0.19, 0.56)	1.11 (0.47, 2.60)	BB
0.22 (0.08, 0.62)	0.77 (0.22, 2.66)	0.69 (0.25, 1.90)	CAI
0.90 (0.51, 1.59)	3.08 (1.26, 7.52)	2.77 (1.58, 4.86)	4.01 (1.38, 11.64)	PGA + BB
0.15 (0.02, 1.04)	0.52 (0.07, 4.02)	0.47 (0.07, 3.21)	0.67 (0.08, 5.68)	0.17 (0.03, 1.06)	PGA + CAI
0.59 (0.22, 1.60)	2.03 (0.70, 5.86)	1.83 (0.70, 4.77)	2.65 (0.69, 10.14)	0.66 (0.25, 1.71)	3.93 (0.49, 31.34)	AA + BB
0.76 (0.27, 2.15)	2.61 (0.75, 9.03)	2.35 (0.88, 6.31)	3.40 (1.08, 10.72)	0.85 (0.32, 2.27)	5.05 (0.62, 40.87)	1.29 (0.35, 4.76)	BB + CAI

Treatment.

IOP≤18 mmHg.

AA = α‐2 adrenergic agonist, BB = beta‐blocker, CAI = carbonic anhydrase inhibitors, PGA = prostaglandin analogue, PLA = placebo.